A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Published by National Coordinating Centre for Health Technology Assessment in 2006. Publication and catalogue information, links to buy online and reader comments.